1. Introduction {#sec0005}
===============

*Porcine reproductive and respiratory syndrome virus* (PRRSV) encompasses two species, *Betaarterivirus suid 1* and *Betaarterivirus suid 2* (formerly, PRRSV-1 and PRRSV-2, respectively) ([@bib0135]), which present a wide inter- and intra-species viral diversity ([@bib0020]; [@bib0265]; [@bib0300]). Since 2006, different outbreaks characterised by high morbidity and mortality rates, fever, haemorrhages, severe lesions in lung and, eventually, in other organs such as thymus or lymph nodes, have been reported associated with virulent PRRSV-1 strains ([@bib0045]; [@bib0150]; [@bib0195], [@bib0200]; [@bib0210]; [@bib0290]; [@bib0345]). Several contradictory results about viraemia, tissue viral load, early virus clearance, low frequencies of PRRSV-specific IFN-γ secreting cells or PRRSV neutralizing antibodies have been reported after infection with PRRSV-1 virulent strains. However, there is consensus on the fact that some strains are more virulent than others ([@bib0045]; [@bib0095]; [@bib0105]; [@bib0110]; [@bib0195]; [@bib0225]; [@bib0300]; [@bib0345], [@bib0350]).

PRRSV replicates predominantly in the lung, causing a mild to severe interstitial pneumonia which may be complicated to suppurative bronchopneumonia due to the increased lung sensitisation to bacterial infections associated with the damage and impairment of the different pulmonary macrophage subpopulations (pulmonary alveolar macrophages, PAMs; pulmonary intravascular macrophage, PIMs; and interstitial macrophages) ([@bib0035]; [@bib0305]). PAMs are the main cellular target of PRRSV, although interstitial and intravascular macrophages can be infected too ([@bib0025]; [@bib0080]; [@bib0125]), with the nucleocapsid protein N (PRRSV*-N-*protein) as the most abundant viral protein during PRRSV infection ([@bib0240]). PAMs express high levels of CD163 scavenger receptor ([@bib0250]; [@bib0315]) which is essential to support PRRSV internalisation and disassembly interacting with GP2 and GP4 viral proteins ([@bib0040]; [@bib0070]; [@bib0355]). A soluble form of CD163 (sCD163), that may be released from tissue macrophages and monocytes, has been identified in plasma as potential biomarker for macrophage activity and inflammation ([@bib0060]; [@bib0190]; [@bib0215]).

PRRSV is known to modulate the host immune response by inducing changes in the frequencies of immune cell subsets in blood ([@bib0075]; [@bib0095]; [@bib0195]; [@bib0345]) and in tissues ([@bib0125]; [@bib0230]), leading to an enhanced susceptibility to secondary bacterial infections ([@bib0150]; [@bib0225]; [@bib0290]). An early decrease in the frequency of monocytes, NK cells or cytotoxic T cells linked to a strong inflammatory response in target organs has been described upon experimental infection with PRRSV-1 virulent strains ([@bib0095]; [@bib0195]; [@bib0345]; [@bib0350]). In addition, some studies indicate an early overproduction of pro-inflammatory cytokines, such as IFN-γ, IL-1β or IL-8, as the main source of pulmonary injury after infection with virulent PRRSV-1 strains ([@bib0010]; [@bib0195]; [@bib0225]; [@bib0350]). Nevertheless, other potential mechanisms, such as an imbalance among pro- and anti-inflammatory responses, might predispose to secondary infections contributing to the onset of the porcine respiratory disease complex (PRDC) ([@bib0130]; [@bib0320]).

In this context, overproduction of nitric oxide (NO), mainly triggered by inducible NO synthase (iNOS) ([@bib0005]), or upregulation of CD14, as the primary lipopolysaccharide (LPS) receptor ([@bib0365]), could contribute to lung inflammation upon infection with PRRSV ([@bib0050]; [@bib0160]; [@bib0320], [@bib0325]; [@bib0360]). By contrast, the transcription factor forkhead box protein 3 (FoxP3), is an essential transcription factor for the development of regulatory T cells (Tregs) and hence, a useful marker to detect them. This subset could be involved in supressing the activation of other T-cell populations ([@bib0155]). CD200 receptor 1 (CD200R1), expressed on myeloid cells and B cell subsets ([@bib0220]), is an inhibitory surface receptor that might deliver inhibitory signals dampening the activation of cells which express it ([@bib0310]). Thus, both immune markers might play an important role inhibiting the production of pro-inflammatory cytokines ([@bib0085]; [@bib0205]; [@bib0285]; [@bib0310]; [@bib0340]), lessening the exuberant lung injury observed with virulent PRRSV-1 strains. Whereas all these markers may play a key role in PRRSV virulence, there are scarce studies analysing their role in the context of the lung lesion. Therefore, the systemic immune response and immunopathology of lung are evaluated in this study with the goal of exploring the role of selected immune markers in the pro- and anti-inflammatory priming of the lung to secondary bacteria after infection with a virulent PRRSV-1 strain (subtype 3, Lena strain) in comparison with a low virulent PRRSV-1 strain (subtype 1, 3249 strain).

2. Materials and methods {#sec0010}
========================

2.1. Porcine reproductive and respiratory syndrome strains {#sec0015}
----------------------------------------------------------

The low virulent 3249 strain (subtype 1 PRRSV-1) was isolated from the serum of a piglet with pneumonia from a PRRSV-positive herd located in Spain in 2005 ([@bib0120]). The virulent Lena strain (subtype 3 PRRSV-1) is considered as the prototype of PRRSV-1 virulent strains. Lena strain isolation was performed from lung homogenates obtained from weak born piglets from a PRRSV-positive herd from Belarus in 2007 with a high mortality rate, reproductive failure and respiratory disorders ([@bib0150]). Viral stocks were produced from the 4th passage of each strain on PAMs, titrated by means of immunoperoxidase monolayer assay and expressed as tissue culture infectious doses 50 (TCID~50~)/mL (3249 strain: 10^5.79^ TCID~50~/mL; Lena strain: 10^5.66^ TCID~50~/mL).

2.2. Animals and experimental design {#sec0020}
------------------------------------

The animals and samples used in this study were part of a project to investigate the pathogenesis of the infection with PRRSV-1 strains of different virulence ([@bib0235]). Briefly, fifty-two 4-week-old male and female piglets (Landrace x Large White crossbred) were obtained from a historically PRRSV-negative farm. All pigs were negative for porcine circovirus type 2 (PCV2), PRRSV and *Mycoplasma hyopneumoniae* by ELISA and PCR assays ([@bib0185]; [@bib0270]).

Piglets were blocked by weight and sex and randomly assigned to three different groups and housed in separate pens: Lena group (n = 20), 3249 group (n = 20) and control group (n = 12). After an acclimation period of seven days, piglets were intranasally inoculated with either the low virulent 3249 strain or the virulent Lena strain (both used at 1 × 10^5^ TCID~50~/mL, 1 mL/nostril, using the MAD Nasal™ Intranasal Mucosal Atomization Device, Teleflex, Alcalá de Henares, Madrid, Spain). The control group was mock-inoculated with the PAM supernatant diluted with RPMI similarly to the inoculum. Three control pigs and five infected pigs from each group were euthanised on days 1, 3, 6 and 8 post-inoculation (dpi). This experiment was conducted according to the guidelines of the European Union (Directive 2010/63/EU) and approved by the IRTA Ethics Committee and by the Catalan Autonomous Government (Project 3647; FUE-2017-00533413).

2.3. Clinical signs, gross pathology and histopathology of lung {#sec0025}
---------------------------------------------------------------

Commencing 1 day prior to inoculation, piglets were daily monitored to evaluate clinical signs (liveliness, respiratory symptoms and anorexia) and rectal temperature. Quantification of clinical signs was performed by applying the following clinical score: liveliness (score 0, no abnormalities; score 1, reduced liveliness but with response to external stimuli; score 2, pig prostration; score 3, agonic pig); respiratory symptoms (score 0, no abnormalities; score 1, mild dyspnoea; score 2, evident dyspnoea; score 3, evident dyspnoea with tachypnoea; score 4, evident dyspnoea, tachypnoea and cyanosis); and anorexia (score 0, eating without abnormality; score 1, sporadic frequency of eating; score 2, no eating). The sum of these scores represented the total clinical score per animal and per day. Rectal temperatures \> 40.5 °C were considered hyperthermia. At necropsy, gross lung lesions were recorded and scored by the same pathologist ([@bib0145]). Afterwards, samples from apical, medial and caudal lobes from the right lung were collected and fixed in 10 % neutral-buffered formalin (Fisher Scientific Ltd., Loughborough, UK) for histopathological and immunohistochemical studies.

Four-micron tissue sections were stained with haematoxylin and eosin and blindly graded by two pathologists for the histopathological evaluation. The severity of histopathological lesions in the lung was scored as previously described by [@bib0145]: 0, no microscopic lesions; 1, mild interstitial pneumonia; 2, moderate multifocal interstitial pneumonia; 3, moderate diffuse interstitial pneumonia; and 4, severe interstitial pneumonia. In addition, a similar score was developed considering the diagnosis of suppurative bronchopneumonia ([@bib0235]): 0, no microscopic lesions; 1, mild bronchopneumonia; 2, moderate multifocal bronchopneumonia; 3, moderate diffuse bronchopneumonia; and 4, severe bronchopneumonia. Altogether, the final score included the total of both, the interstitial pneumonia score and the bronchopneumonia score, being 8 points the maximum possible score.

2.4. Viral genome quantification {#sec0030}
--------------------------------

RNA was isolated from sera using NucleoSpin® RNA virus (Macherey-Nagel, Düren, Germany) according to manufacturer's instructions. For lung, RNA was purified from tissue homogenate using a combined procedure with TRIzol™ (Thermo Fisher Scientific, Barcelona, Spain) and NucleoSpin® RNA Virus columns (Macherey-Nagel) according to manufacturer's instructions. Viral load for either 3249 strain or Lena strain was quantified by RT-qPCR using VetMAX™ PRRSV EU/NA 2.0 kit (Thermo Fisher Scientific, Barcelona, Spain). Amplifications were performed in duplicate from each animal in the QuantStudio 5 Real-time PCR System (Thermo Fisher Scientific) for 5 min (min) at 50 °C, 10 min at 95 °C followed by 40 cycles of 3 s (s) at 95 °C and 30 s at 60 °C. PRRSV RNA quantification was performed using specific primers of the target gene (Lena strain ORF7: forward primer AGCGCCAATTCAGAAAGAAA, reverse primer TGGATCGATTGCAGACAGAG; 3249 strain ORF7: forward primer GGCAAACGAGCTGTTAAACG, reverse primer AATTTCGGTCACATGGTTCC; [@bib0065]). The ORF7 RT-PCR product from both 3249 and Lena strains was firstly EtOH precipitated and purified using ExoSAP-ITTM (Thermo Fisher Scientific, Barcelona, Spain). The purified products were quantified using BioDrop (BioDrop, UK). Serial 10-fold dilutions of 3249 or Lena ORF7 RT-PCR products with known quantities, ranging from 10^8^ to 10^2^ genomic copies/mL were used as standards to generate a standard curve and, therefore, to determine the PRRSV genomic copies in sera and lung. The RT-qPCR efficiency (E) was estimated for each strain by a linear regression model. The E value was calculated from the slope of the standard curve according to equation: E = 10^(−1/slope)^ -1. Also, a set of eight serial 10-fold dilutions of know TCID~50~/mL (starting from 10^6^ TCID~50~/mL) was included in order to determine a relation between Ct-values, genomic copies/mL and TCID~50~/mL. An inter-run calibrator sample with a known number of PRRSV copies was introduced in each experiment to self-control inter-run variation. The area under the curve (AUC) for viremia and lung viral load was calculated using the trapezoidal approach ([@bib0140]). Results of viral load in sera and lung are showed in equivalent TCID ~50~ (eq TCID~50~) per mL.

2.5. Antibody and serological assessments {#sec0035}
-----------------------------------------

Specific antibodies against PRRSV were detected using IDEXX PRRS X3 ELISA test (IDEXX laboratories, Barcelona, Spain) following manufacturer's instructions. Levels of IFN-γ, IL-6 and IL-10 and the acute phase protein lipopolysaccharide binding protein (LBP) as well as the soluble form of swine CD163 (sCD163) were assessed in sera from all piglets. Different commercially available ELISA tests were used in accordance with manufacturer's guidelines (IFN-γ, IL-6, IL-10 \[Invitrogen, Barcelona, Spain\]; LBP, \[Hycult Biotech, Uden, Netherlands\]; sCD163 \[Cusabio Biotech, Houston, USA\]). Results were expressed in pg/mL for IFN-γ, IL-6 and IL-10, and ng/mL for LBP and sCD163. The minimum detectable concentrations were 2 pg/mL for IFN-γ, 45 pg/mL for IL-6, 3 pg/mL for IL-10, 1.6 ng/mL for LBP and 23.4 ng/mL for sCD163.

2.6. Immunohistochemistry in lung tissue {#sec0040}
----------------------------------------

Four-micron sections from lung were dewaxed in xylene and rehydrated in descending grades of alcohol until distilled water. Then, endogenous peroxidase inhibition was performed in a 3 % H~2~O~2~ solution in methanol for 30 min. Epitope demasking, primary antibodies dilutions and blocking of non-specific binding are detailed in [Table 1](#tbl0005){ref-type="table"} . Monoclonal primary antibodies were incubated overnight at 4 °C in a humid chamber. Polyclonal goat anti-mouse immunoglobulins (Agilent Technologies, Madrid, Spain) or polyclonal goat anti-rabbit immunoglobulins (Vector laboratories, USA) biotinylated secondary antibodies were accordingly incubated for 30 min at room temperature. After washing in PBS, Avidin--Biotin--Peroxidase complex technique (ABC Vector Elite, Vector laboratories, USA) was applied and the immunolabelling was revealed by application of NovaRED™ substrate kit (Vector Laboratories). Sections were counterstained with Harris's haematoxylin, dehydrated and mounted. PBS (pH 7.4) and Tris buffered saline (pH 7.6) were used as wash and diluent buffers, respectively. Antibody specificity was verified by exchanging the primary antibody by isotype matched reagents of irrelevant specificity. One negative control which consisted of replacement of the primary antibody by BSA blocking solution was included in each immunohistochemical assay to rule out non-specific bindings.Table 1Summary of immunohistochemical methodology.Table 1SpecificityType of antibodiesCloneSourceBlocking solutionDilutionAntigen retrievalPRRSV-N- proteinmAbSDOW17Rural Technologies, Brookings, SD, USABSA 2 %1:500Protease XIVCD163mAb2A10/11In house, INIANGS 10 %neatCitrate pH 6CD200R1mAbPCT3In house, INIABSA 2 %neatProtease XIVCD14mAbMIL2Biorad, Hercules, CABSA 2 %1:100Protease XIViNOSpAbNANeomarers, Fremont, CA, USABSA 2 %1:750Citrate pH 6\*FoxP3mAbFJK-16seBioscience™, Bacelona, SpainNGS 10 %\*\*1:100Citrate pH 6\*[^1]

2.7. Immunohistochemistry cell counting {#sec0045}
---------------------------------------

The number of immunolabelled cells was quantified in 25 non-overlapping selected high magnification fields of 0.2 mm^2^ (Olympus BX51, Olympus Iberia SAU, L'Hospitalet de Llobregat, Barcelona, Spain) and expressed as the mean of the score for each animal per mm^2^. Labelled cells were morphologically identified by differentiating among PAMs, PIMs and interstitial macrophages.

2.8. Statistical analyses {#sec0050}
-------------------------

Differences between groups were evaluated for approximate normality of distribution by the D'Agostino and Pearson omnibus normality test followed by the Mann Whitney's U non-parametric mean comparisons test. Correlation coefficients were assessed by the Spearman and Pearson tests and were considered relevant with r \> 0.6 and *P* \<  0.05. Data analyses and figures were performed by using GraphPad Prism 7.0 software (GraphPad Prism software 7.0, Inc., San Diego, CA, USA) and InkScape 0.92 software. A *P* value lower than 0.05 was considered statistically significant and represented as \* *P* ≤  0.05, \*\* *P* ≤  0.01 \*\*\* *P* ≤  0.001 and \*\*\*\* *P* ≤  0.0001.

3. Results {#sec0055}
==========

3.1. Acute suppurative bronchopneumonia and the highest rectal temperature and clinical signs score were observed in Lena-infected pigs {#sec0060}
---------------------------------------------------------------------------------------------------------------------------------------

Clinical observations and gross pathology of lung were described thoroughly by [@bib0235]. In brief, piglets inoculated with virulent Lena strain had a long period of hyperthermia (mean rectal temperature above 40.5 °C) with marked clinical signs score from 4 dpi onwards, both peaking at 6 dpi ([Fig. 1](#fig0005){ref-type="fig"} **A**-**B**, clinical signs score and temperature). By contrast, an increase in rectal temperature below the hyperthermic threshold accompanied by mild clinical signs was observed in piglets infected with 3249 strain ([Fig. 1](#fig0005){ref-type="fig"} **A**-**B**). At necropsy, tan-mottled areas, atelectasis, rubbery consistency, and consolidated areas were observed in the lungs from both PRRSV-1-infected pigs whose macroscopic lung score gradually increased throughout the study ([Fig. 1](#fig0005){ref-type="fig"} **C**-**D**). In particular, a stronger and earlier onset of the lung lesion (from 6 dpi onwards) associated with the presence of extensive consolidated areas in apical and medial lobes as well as more severe interstitial pneumonia were observed in Lena-infected pigs causing the highest macroscopic lung score compared to 3249-infected pigs ([Fig. 1](#fig0005){ref-type="fig"} **C**-**D**).Fig. 1**Clinical signs score, macroscopic and microscopic lung outcomes.** Clinical signs and temperature were recorded from 1 day prior to infection until 8 dpi to evaluate clinical signs and hyperthermia (\> 40.5 °C). Plots show the mean average of clinical signs score **(A)** and rectal temperature **(B)** for control group (gray circles), 3249-infected group (green triangle) and Lena-infected group (red diamonds). "a" indicates a significant difference between the Lena and 3249 and control groups, "b" a significant difference between the Lena and 3249 groups and "c" a significant difference between the 3249 and control groups. *P* value lower than 0.05 was considered statistically significant and represented as \* *P* ≤  0.05, \*\* *P* ≤  0.01 and \*\*\* *P* ≤  0.001. Days post-inoculation, dpi. **(C)** At necropsy, lungs were scored and processed for histological and immunohistochemical studies. Box plots display the macroscopic lung score for each group (control, gray circles; 3249, green triangles; Lena, red diamonds) for each time point. *P* value lower than 0.05 was considered statistically significant and represented as \* *P* ≤  0.05, \*\* *P* ≤  0.01 and \*\*\* *P* ≤  0.001. Days post-inoculation, dpi. **(D)** Lung appearance of piglets from the control, 3249 and Lena group at 8 dpi are shown in the pictures. **(E)** Box plots show the microscopic lung score for each group (control, gray circles; 3249, green triangles; Lena, red diamonds) for each time point. Each symbol represents individual data for each pig. *P* value lower than 0.05 was considered statistically significant and represented as \* *P* ≤  0.05, \*\* *P* ≤  0.01 and \*\*\* *P* ≤  0.001. Days post-inoculation, dpi. **(F)** Photomicrographs of the medial lung lobe illustrate characteristic interstitial pneumonia in a representative 3249-infected pig (left) and suppurative bronchopneumonia in a representative Lena-infected pig (right) at 8 dpi. Haematoxylin and eosin. Bar, 100 μm.Fig. 1

A mild to moderate interstitial pneumonia with thickening of the alveolar septa by infiltrate of lymphocytes and macrophages was caused by both Lena and 3249 strains ([Fig. 1](#fig0005){ref-type="fig"} **E**-**F**). Furthermore, a suppurative bronchopneumonia characterised by neutrophils, cell debris and mucus filling the bronchial, bronchiolar and alveolar lumen was observed in lung section from Lena-infected pigs at 6 and 8 dpi ([Fig. 1](#fig0005){ref-type="fig"} **E**-**F**). A strong statistical correlation was found among temperature, clinical signs score, macroscopic and microscopic lung scores in Lena-infected pigs ([Table 2](#tbl0010){ref-type="table"} ).Table 2Statistical correlations found in piglets infected with virulent Lena strain throughout the study. For all data, a *P* value lower than 0.05 was considered statistically significant and represented as \* *P* ≤  0.05, \*\* *P* ≤  0.01, \*\*\* *P* ≤  0.001 and \*\*\*\**P* ≤  0.0001.Table 2TemperatureClinical scoreViraemiaLung viral LoadIFN-γIL-6Gross lesionMicroscopic lesionPRRSV-N-proteinCD163CD200R1FoxP3CD14iNOSTemperature--0.92\*\*\*\*0.79\*\*\*\*0.76\*\*\*\*0.67\*NS0.62\*\*0.64\*\*0.78\*\*\*\*NSNSNSNSNSClinical signs score--0.84\*\*\*\*0.72\*\*\*\*0.72\*\*\*NS0.68\*\*0.75\*\*\*\*0.78\*\*\*\*NS−0.63\*\*NSNSNSViraemia--0.77\*\*\*\*0.71\*\*NSNS0.62\*\*0.74\*\*−0.78\*\*\*NSNSNSNSLung viral load--0.71\*\*\*NS0.72\*\*\*0.68\*\*0.85\*\*\*\*−0.71\*\*\*0.63\*\*NSNSNSIFN-γ--NSNS0.62\*0.62\*NS0.61\*\*0.70\*\*NSNSIL-6--NSNS0.55\*NS0.56\*NS0.84\*\*\*NSGross lesion--0.8\*\*\*NSNS0.73\*\*\*NSNSNSMicroscopic lesion--0.68\*\*NS0.91\*\*\*\*NSNSNSPRRSV-N-protein--−0.62\*\*0.63\*\*NSNSNSCD163--NSNSNSNSCD200R1--NS0.55\*NSFoxP3--NSNSCD14--0.52\*iNOS--[^2]

3.2. Viraemia and lung viral load followed a similar kinetics in PRRSV-1-infected pigs {#sec0065}
--------------------------------------------------------------------------------------

Viraemia and lung viral load were determined by RT-qPCR (efficiency of 99 %; slope = 3.34; detection limit: 1 copy/μl; slope-intercept = 39.5; and high linearity, r = 0.99). All animals were negative by RT-qPCR at day 0 and control pigs remained so all throughout the experiment. In sera, four out of five 3249-infected pigs and all Lena-infected pigs were PRRSV positive as early as 1 dpi. Viraemia was always higher in Lena- than in 3249-infected pigs from 1 to 8 dpi (*P* \< 0.01 at 1, 3, 6 dpi; *P* \< 0.05 at 8 dpi), reaching the highest viral load at 6 dpi (1.9 × 10^7^ eq TCID~50~/mL). The AUC for viremia (mean) in Lena and 3249 group were 44.8 and 33.8 respectively ([Fig. 2](#fig0010){ref-type="fig"} **A**). The viral load in the lung displayed a similar kinetics to that of serum for both infected groups, reaching the maximum lung viral loads at 6 dpi in Lena group (1.6 × 10^7^ eq TCID~50~/mL), whereas 3249 group peaked at 8 dpi (1.9 × 10^6^ eq TCID~50~/mL) ([Fig. 2](#fig0010){ref-type="fig"} **B**). By contrast to sera, PRRSV-1 was just detected in lung in two out of five animals in both infected groups at 1 dpi, being positive all infected piglets from 3 dpi onwards. The AUC for lung viral load (mean) in Lena group was 45 and 36.2 for 3249 group ([Fig. 2](#fig0010){ref-type="fig"} **B**). In Lena infected-group the statistical analysis revealed a positive correlation among viraemia, lung viral load, temperature, clinical signs score and the number of PRRSV*-N-*protein^+^ cells in the lungs ([Table 2](#tbl0010){ref-type="table"}). A correlation among lung viral load and viraemia and PRRSV*-N-*protein^+^ cells was also observed in 3249-infected pigs (r = 0.71, *P* \<  0.0001; and, r = 0.60, *P* \<  0.005, respectively).Fig. 2**PRRSV viraemia, lung viral load, IFN-γ and IL-6 level in sera.** PRRSV viral load was quantified in sera **(A)** and lung **(B)** by RT-qPCR. The concentration of IFN-γ **(C)** and IL-6 **(D)** were assessed in sera by using ELISA. Diagrams (**A**) and (**B**) display the viral load (eq TCID~50~/mL) and (**C)** and (**D)** the concentration of the cytokines IFN-γ (pg/mL) and IL-6 (pg/mL), respectively, for each group (control, gray circles; 3249, green triangles; Lena, red diamonds) and time point. All data are reported as the mean with range of results obtained for each group and time point. *P* value lower than 0.05 was considered statistically significant and represented as \* *P* ≤  0.05 and \*\* *P* ≤  0.01. "a" indicates a significant difference between the Lena and 3249 and control groups and "b" a significant difference between the 3249 and control groups. Days post-inoculation, dpi.Fig. 2

3.3. A significant increase in the serum concentration of IFN-γ was observed in Lena-infected pigs when compared with 3249-infected pigs {#sec0070}
----------------------------------------------------------------------------------------------------------------------------------------

PRRSV-specific antibodies were first detected at 8 dpi in sera from both PRRSV-1-infected groups (non-significant differences in S/P ratios) (data not shown). A significant increase in IFN-γ serum levels was detected after Lena infection at 6 and 8 dpi (maximum mean level of 234 ± 100 pg/mL at 6 dpi) compared to control (*P* \< 0.05) and 3249 (*P* \< 0.01) groups ([Fig. 2](#fig0010){ref-type="fig"} **C**). Maximum IL-6 levels in serum of 3249 group were observed at 6 dpi (mean of 350 ± 220 pg/mL), whereas pigs belonging to Lena group reached the highest IL-6 levels at 8 dpi (mean of 480 ± 50 pg/mL) ([Fig. 2](#fig0010){ref-type="fig"} **D**). IL-10, LBP or sCD163 were not detected in serum samples from both control and infected groups throughout the study. Both viraemia and lung viral load displayed a positive statistical correlation with IFN-γ levels, which in turn were also correlated with temperature and the clinical signs score in Lena infected-pigs ([Table 2](#tbl0010){ref-type="table"}).

3.4. The increase in the number of PRRSV*-N-*protein^+^ cells was associated with a decrease of CD163^+^ macrophages in the lung of PRRSV-infected pigs {#sec0075}
-------------------------------------------------------------------------------------------------------------------------------------------------------

The labelling of PRRSV*-N-*protein was mainly observed in PAMs and in a lesser extent in interstitial and intravascular macrophages ([Fig. 3](#fig0015){ref-type="fig"} **A**-**B**). In Lena-infected pigs, clusters of PRRSV*-N-*protein^+^ macrophages were observed within foci of bronchopneumonia at 6 and 8 dpi ([Fig. 3](#fig0015){ref-type="fig"} **B** inset). A progressive increase in the number of PRRSV*-N-*protein^+^ cells was detected throughout the study in both PRRSV-1-infected groups, reaching a peak at 6 and 8 dpi in Lena and 3249-infected piglets, respectively. This increase was significantly higher in Lena than in 3249 group (*P* \< 0.05 at 3, 6 and 8 dpi) ([Fig. 3](#fig0015){ref-type="fig"} **E**, primary axis). No positive cells were detected in control pigs.Fig. 3**Immunohistochemical expression of PRRSV*-N-*protein and CD163 in lung tissue.** Lung tissue sections were immunolabelled for both antigens. Photomicrographs of the medial lung lobe illustrate the expression of PRRSV*-N-*protein in a 3249-infected (**A**) and Lena-infected (**B**) pig, which was mainly observed in PAMs (3A-3B, insets). IHC. Bar, 100 μm. Photomicrographs of the medial lung lobe illustrate the expression of CD163 in a representative control (**C**) and Lena-infected (**D**) pig. Immunolabelling of CD163 scavenger receptor was mainly observed in the cytoplasm and cell surface of PAMs found in the pulmonary alveolus and in a lesser extent in interstitial and intravascular macrophages (3C-3D, insets). IHC. Bar, 50 μm. **(E)** The diagram displays the number of PRRSV*-N-*protein^+^ (primary axis) and CD163^+^ (secondary axis) cells/mm^2^. Scatter dot plot shows the number of CD163^+^ macrophages (secondary axis) for each animal (control, gray circles; 3249, green triangles; Lena, red diamonds) and coloured lines the average for each group and time point. Control baseline displays the mean of the number of positive cells along the study in control group. *P* value lower than 0.05 was considered statistically significant and represented as \* *P* ≤  0.05 and \*\* *P* ≤  0.01. The grey bars display the average of total number of PRRSV*-N-*protein^+^ macrophages (primary axis) for each group and time point. "a" indicates a significant difference between the Lena and 3249 groups. Days post-inoculation, dpi.Fig. 3

CD163 immunolabelling was detected in the cell membrane and cytoplasm of PAMs, interstitial macrophages and, occasionally, intravascular macrophages ([Fig. 3](#fig0015){ref-type="fig"} **C**-**D**, insets). A drop in the number of CD163^+^ cells was observed from 3 to 8 dpi in both PRRSV-1-infected groups. This decrease was more intense in Lena-infected animals when compared to 3249 (*P* \< 0.05 at 3 dpi) and control groups (*P* \< 0.05 at 3 and 8 dpi) ([Fig. 3](#fig0015){ref-type="fig"} **E**, secondary axis). By contrast, the frequency of CD163^+^ cells remained constant in control pigs during the whole study. Of note, PAMs were the subset of pulmonary macrophages which underwent the strongest reduction in the number of CD163^+^ cells. Furthermore, the frequency of CD163^+^ cells showed a strong negative correlation with lung viral load and the number of PRRSV*-N-*protein^+^ cells in Lena infected-pigs ([Fig. 3](#fig0015){ref-type="fig"} **E**) ([Table 2](#tbl0010){ref-type="table"}).

3.5. A strong influx of CD14^+^ macrophages and monocytes infiltrating the interstitium was detected in Lena-infected pigs {#sec0080}
--------------------------------------------------------------------------------------------------------------------------

The labelling against CD14 was mainly observed in the cell membrane and cytoplasm of monocytes, interstitial and intravascular macrophages and, occasionally, in PAMs ([Fig. 4](#fig0020){ref-type="fig"} **A**-**B**, insets). Whereas no changes were observed in the number of CD14^+^ cells in the control group along the study, a gradual increase with maximum expression at 8 dpi was detected in both infected groups ([Fig. 4](#fig0020){ref-type="fig"} **E**). Lena-infected pigs showed the highest frequency of CD14^+^ cells when compared to control animals (*P* \< 0.01) in association with the presence of suppurative bronchopneumonia ([Fig. 4](#fig0020){ref-type="fig"} **B**). CD14^+^ interstitial and intravascular macrophages were observed infiltrating extensive areas of the interstitium, whereas almost no CD14^+^ cells were present in the bronchial wall and alveolar lumen. Interestingly, the number of CD14^+^ cells in Lena-infected piglets displayed a strong positive correlation with the concentration of IL-6 in sera ([Table 2](#tbl0010){ref-type="table"}).Fig. 4**Immunohistochemical expression of CD14 and iNOS in lung tissue**. Lung tissue sections were immunolabelled for both antigens. Photomicrographs of the medial lung lobe illustrate the expression of CD14 in a 3249-infected (**A**) and Lena-infected pig (**B**), which was mainly expressed on the cell membrane and cytoplasm of monocytes, interstitial and intravascular macrophages (4A-4B, insets). IHC. Bar, 100 μm. Photomicrographs of the medial lung lobe illustrate the expression of iNOS in a representative control (C) and Lena-infected (D) pig. iNOS was observed primarily in the cytoplasm of PAMs and interstitial macrophages detected in foci of interstitial pneumonia and bronchopneumonia (4C-4D, insets). IHC. Bar, 100 μm. **(E)** Box plots shows the number of CD14^+^ cells/mm^2^ for each group (control, gray circles; 3249, green triangles; Lena, red diamonds) and time point. **(F)** Box plots display the number of iNOS^+^ cells for each group (Control, gray circles; 3249, green triangles; Lena, red diamonds) and time point. Control baseline displays the mean of the number of positive cells along the study in control group. *P* value lower than 0.05 was considered statistically significant and represented as \* *P* ≤  0.05 and \*\* *P* ≤  0.01. Days post-inoculation, dpi.Fig. 4

3.6. Lena virulent strain induced a strong increase of iNOS^+^ cells associated with a higher microscopic lung lesion {#sec0085}
---------------------------------------------------------------------------------------------------------------------

The granular intracytoplasmic immunostaining of iNOS was primarily observed in PAMs and interstitial macrophages in foci of interstitial pneumonia and bronchopneumonia ([Fig. 4](#fig0020){ref-type="fig"} **C**-**D**). The number of iNOS^+^ cells followed a similar kinetics in both PRRSV-1-infected groups, with a progressive increase from 6 dpi onwards, reaching a significant increase by the end of the study (8 dpi) in Lena-infected pigs compared to 3249 (*P\<*0.01) and control groups (*P\<*0.05) ([Fig. 4](#fig0020){ref-type="fig"} **F**).

3.7. The increase of CD200R1^+^ cells along the study was highly correlated with the course of lung injury {#sec0090}
----------------------------------------------------------------------------------------------------------

CD200R1 labelling was detected in the cytoplasm of intravascular and interstitial macrophages located inside or surrounding bronchopneumonia foci, with occasional expression in PAMs and monocytes ([Fig. 5](#fig0025){ref-type="fig"} **A**-**B**, insets). Whereas the number of CD200R1^+^ cells significantly increased in Lena-infected pigs at 6--8 dpi (*P* \< 0.05 at 6 dpi with respect to 3249 group; and *P* \< 0.01 at 6 dpi and *P*\<0.05 at 8 dpi with respect to control group), this increase was just detected at 8 dpi in 3249-infected pigs (*P* \< 0.05 with respect to control group) ([Fig. 5](#fig0025){ref-type="fig"} **E**, primary axis). Control animals presented a scarce number of CD200R1^+^ cells along the study. For Lena infected-pigs a strong positive correlation was observed among the frequency of CD200R1^+^ cells and the microscopic lung lesions ([Fig. 5](#fig0025){ref-type="fig"} **E**) ([Table 2](#tbl0010){ref-type="table"}).Fig. 5**Immunohistochemical expression of CD200R1 and FoxP3 in lung tissue.** Lung tissue sections were immunolabelled for both antigens. Photomicrographs of the medial lung lobe illustrate the expression of CD200R1 in a 3249-infected (**A**) and Lena-infected (**B**) pig, which was mainly detected in the cytoplasm of intravascular and interstitial macrophages located inside or surrounding bronchopneumonia foci (5A-5B, insets). IHC. Bar, 50 μm. Photomicrographs of the medial lung lobe illustrate the expression of FoxP3 in a representative control (**C**) and Lena-infected (**D**) pig. FoxP3 yielded a nuclear immunolabelling in lymphocytes mainly located in areas of atelectasis and interstitial pneumonia (5C-5D, insets). IHC. Bar, 100 μm. **(E)** The diagram displays the number of CD200R1^+^ cells/mm^2^*versus* the microscopic lung score. Scatter dot plot shows the number of CD200R1^+^ cells (primary axis) for each animal (control, gray circles; 3249, green triangles; Lena, red diamonds) and coloured lines the average for each group and day point. The gray bar displays the microscopic lung score (secondary axis) for each group (control, gray circles; 3249, green triangles; Lena, red diamonds) at each time point. **(F)** Box plots shows the number of FoxP3^+^ cells for each group (control, gray circles; 3249, green triangles; Lena, red diamonds) and time point. Control baseline displays the mean of the number of positive cells along the study in control group. *P* value lower than 0.05 was considered statistically significant and represented as \* *P* ≤  0.05 and \*\* *P* ≤  0.01. Days post-inoculation, dpi.Fig. 5

3.8. Both PRRSV-1 strains induced an increase of FoxP3^+^ cells at 6--8 dpi {#sec0095}
---------------------------------------------------------------------------

FoxP3 yielded a nuclear immunolabelling in lymphocytes mainly located in areas of atelectasis and interstitial pneumonia ([Fig. 5](#fig0025){ref-type="fig"} **C**-**D**, insets). Although two Lena-infected pigs exhibited a higher number of FoxP3^+^ cells at 1 dpi, the kinetics of positive cells for this immune markers showed a gradual increase along the study in both Lena- and 3249-infected animals, reaching the maximum at 6 dpi ([Fig. 5](#fig0025){ref-type="fig"} **F**). There were no significant differences in the number of FoxpP3^+^ cells among infected groups. However, a significant increase of FoxP3^+^ cells was detected at 6 and 8 dpi in Lena-infected pigs compared to control animals (*P* \< 0.05).

4. Discussion {#sec0100}
=============

PRRSV plays a pivotal role in PRDC, modulating the host immune response and favouring secondary bacterial infections ([@bib0130]; [@bib0320]). Virulent PRRSV-1 strains cause more severe clinical signs, higher mortality rates as well as marked lung injury with a higher incidence of bronchopneumonia as opposed to low virulent strains ([@bib0010]; [@bib0045]; [@bib0105]; [@bib0125]; [@bib0195]; [@bib0225]; [@bib0235]; [@bib0300]; [@bib0345]). Accordingly, we hypothesise that severe pulmonary lesions observed along infection with virulent PRRSV-1 strains might be associated with a higher decrease in the amount of PAMs as well as an imbalance between anti- and pro-inflammatory responses with different molecules potentially involved in this process.

As previously described ([@bib0225]; [@bib0345]), severe systemic and respiratory symptoms as well as hyperthermia were observed in animals infected with virulent Lena strain, whereas low virulent 3249 strain only caused mild clinical signs and a slightly increase of rectal temperature. Furthermore, virulent Lena strain caused an earlier and stronger onset of lung lesions due to extensive consolidated areas in the apical and medial lobes which were microscopically linked to suppurative bronchopneumonia as well as severe characteristic interstitial pneumonia. On the other hand, PRRSV virulence has been associated with higher virus titre and antibody response *in vivo* ([@bib0030]; [@bib0175]) Although Lena virulent strain elicited a quite higher viraemia than the low virulent strain, no differences were observed in the antibody response in the early phase of infection. Similar results have been previously reported by others when comparing Lena with low virulent strains ([@bib0225]; [@bib0345]), and confirm that PRRSV-1 virulence and specific non-neutralizing antibodies are not associated in the acute phase of infection.

PRRSV infection with virulent strains usually induces a strong inflammatory immune response when compared with low virulent strains ([@bib0010]; [@bib0170]; [@bib0195]; [@bib0225]; [@bib0345]). In our study, higher levels of IL-6 at 8 dpi and IFN-γ at 6--8 dpi were detected in the sera of Lena-infected pigs. Increased concentration of IL-6 in plasma is associated with both systemic and respiratory symptoms ([@bib0330]) and could play a dual role during virus infection: (i) protecting the host from infection and (ii) inducing inflammation and tissue damage when it is overexpressed ([@bib0170]). It is known that IFN-γ is, mostly produced by activated NK cells, NKT cells, γ/δ T cells, cytotoxic T cells and memory T cells ([@bib0115]; [@bib0180]), and participates in regulating the immune and inflammatory responses ([@bib0330]). In fact, an early increase of NKT cells has been associated with viraemia peak in piglets infected with PR40 virulent strain ([@bib0095]). In our study, virulent Lena strain elicited a marked increase in the serum level of IFN-γ which was significantly correlated with viremia and lung viral load, suggesting an attempt of the host innate immune response in controlling virus replication. The enhanced serum concentration of IL-6 could mirror the stronger systemic inflammatory response induced by Lena during the acute phase response contributing to the fever and more severe clinical signs as well as lung lesion that specifically arise in virulent PRRSV-1 strains ([@bib0010]; [@bib0225]).

In order to evaluate the kinetics of PRRSV-1 in the lung, we analysed the expression of PRRSV*-N-*protein and lung viral load. Interestingly, both the number of PRRSV*-N-*protein^+^ cells and lung viral load showed a solid negative correlation with the frequency of CD163^+^ cells, the essential host receptor for PRRSV infection ([@bib0040]; [@bib0315]; [@bib0355]). The dramatical depletion in the frequency of pulmonary CD163^+^ cells in Lena-infected animals has been already reported in live PAMs from the BALF of Lena-infected piglets ([@bib0225]; [@bib0235]) as well as from lung tissue sections of piglets infected with virulent SU1-bel strain ([@bib0255]). This finding could be due to the direct cytopathic effect of the virus in its target cell but also to an indirect induction of regulated cell death in infected and non-infected cells, which has been broadly described in the lung and lymphoid organs of pigs infected with virulent PRRSV-1 strains ([@bib0195]; [@bib0245]; [@bib0255]). Another possibility would be the shedding of sCD163 due to macrophages activation either by a direct effect of the virus or secondary to viral infection ([@bib0190]). However, it seems unlikely, since no changes were detected in sCD163 sera concentration in our study after infection with a virulent PRRSV-1 strain. In contrast, *Glaesserella parasuis* virulent strains have been reported to increase serum levels of sCD163 linked to a reduction in CD163 surface expression in PAMs ([@bib0060]). In our study, the decrease of CD163^+^ macrophages, an important cell subset to tackle bacterial infections ([@bib0090]), points out to a mechanism involved in the impairment of the local pulmonary immune response. This fact may potentially favour the co-infection with secondary commensal microorganisms leading to bronchopneumonia.

CD14 and iNOS are involved in lung inflammation after infection with PRRSV ([@bib0050]; [@bib0160]; [@bib0320], [@bib0325]; [@bib0360]) Upregulation of CD14, as lipopolysaccharides (LPS) co-receptor, after infection with PRRSV sensitises the lungs for the production of proinflammatory cytokines and respiratory signs upon exposure to bacterial LPS ([@bib0325]). For its part, iNOS is mainly expressed in response to different stimuli, such as cytokines and LPS, playing a role in tissue injury upon production of NO ([@bib0050]; [@bib0055]; [@bib0335]; [@bib0360]). In this study, an increase in the number of CD14^+^ cells after PRRSV-1 infection was observed in association with suppurative bronchopneumonia, which was more evident in Lena-infected piglets at 6--8 dpi. This increase was mainly due to CD14^+^ monocytes, interstitial and intravascular macrophages infiltrating extensive areas of the interstitium. The influx of CD14^+^ monocytes and immature macrophages may be explained by an attempt to replenish the loss of CD163^+^ macrophages contributing to clearance of cellular debris and resolution of inflammation, restoring the normal lung function. On the other hand, the increase of CD14^+^ cells implies a higher availability of the LPS-LBP complex receptor, which is likely to sensitise the lung to future secondary bacterial infections making the onset of PRDC easier ([@bib0325]). In the case of iNOS, a significant increase in the number of iNOS^+^ cells was observed in areas of interstitial pneumonia as well as bronchopneumonia in Lena-infected pigs. The induction of iNOS has been associated with both a direct effect of the viral replication or viral components and an indirect effect mediated by cytokines, such as IFN-γ, or by LPS (Akaike and Maeda, 2000; [@bib0050]; [@bib0160]). Of note, the peak of iNOS in Lena-infected animals appeared in our study just after the peak of PRRSV replication in the lung as well as after the peak of serum IFN-γ, being associated with the maximum lung injury and bronchopneumonia lesion. These factors may play a role in the regulation of iNOS expression along PRRSV infection and its role in lung injury development ([@bib0050]; [@bib0160]; [@bib0360]).

After a cascade of proinflammatory events, the host is able to trigger off the release of anti-inflammatory or regulatory mediators to restrain the extent of the injury. Thus, the role of CD200R1 and FoxP3 was evaluated in the present study. A strong positive correlation was detected among the frequency of CD200R1^+^ cells and the microscopic score which was mainly associated with a higher severity of typical interstitial pneumonia and suppurative bronchopneumonia in Lena-infected pigs. Likewise, an increase in the frequency of FoxP3^+^ cells between 6 and 8 dpi was triggered by both PRRSV-1 strains when the lung injury was higher. CD200R1 has been involved in reducing the expression of pro-inflammatory cytokines in a wide range of inflammatory diseases ([@bib0310]), nevertheless to the best of the authors' knowledge, the role of CD200R1 in viral diseases of swine is largely unknown. Previous studies in a murine model reported that influenza virus infection induced the upregulation of CD200R1 in macrophages, decreasing their responsiveness and increasing the sensitivity to bacterial infection and finally severe lung injury ([@bib0295]; [@bib0310]). In contrast, CD200/CD200R1 signalling pathway limited type I IFN production during coronavirus infection protecting the host from cytokine storm ([@bib0310]). In addition, FoxP3 has been reported as a potential inhibitor of the cell-mediated immune response in pigs upon PRRSV infection ([@bib0100]; [@bib0275], [@bib0280]); but also induction of Tregs has been described in the lungs and tracheobronchial lymph nodes in PRRSV-infected pigs ([@bib0205]). However, its role in the immunopathogenesis of PRRSV-induced lung injury is unexplored. PD1/PDL1 modulation and FoxP3^+^ cells have been pointed out to play a dual role upon viral infections, restricting immune inflammation-induced tissue damage and encouraging lung repair during acute phase of infection ([@bib0165]; [@bib0285]), but leading to exhaustion and suppression of antiviral immune responses in the chronic infection ([@bib0015]; [@bib0260]; [@bib0340]). Taken together, our results highlight the upregulation of CD200R1 and FoxP3 as mechanisms involved in the constraint and recovery of lung injury during acute PRRSV infection. Further studies are needed to determine the mechanisms involved in the activation of these molecules during acute PRRSV as well as their role and related signalling pathways along the persistent infection.

5. Conclusion {#sec0105}
=============

The present study dissects the immunopathology of lung injury along an acute infection with PRRSV-1 strains of different virulence, revealing a drop in the number of CD163^+^ cells together with an enhancement in the expression of CD14 and iNOS as mechanisms involved in the earlier and higher extent of lung lesion in Lena-infected piglets. These changes could sensitise the lung to future secondary bacterial infections. In addition, the increase in the number of CD14^+^ cells is likely to respond to an attempt to replenish the CD163^+^ macrophages subset lost along the infection with both PRRSV-1 strains. On the other hand, the increase in the expression of CD200R1 and FoxP3 represents potential pathways activated to contain the inflammatory response.
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[^1]: PRRSV, *Porcine reproductive and respiratory syndrome virus*; CD200R1, CD200 Receptor 1; iNOS, inducible nitric oxide synthase; FoxP3, forkhead box protein 3; mAb, monoclonal antibody; pAb, polyclonal antibody; BSA, Bovine Serum Albumin; NGS, Normal Goat Serum; NA, not applicable; Citrate pH 6, microwave heat treatment at 420 W for 10 min; Protease XIV, enzymatic digestion with protease type XIV (Sigma-Aldrich) at 38 °C for 8 min; Citrate pH 6\*, autoclave treatment at 121 °C for 10 min; NGS 10 %\*\*: NGS diluted in phosphate buffer saline with 10 % tween 20.

[^2]: NS: not statistically significant or with r \< 0.6. Correlation coefficients were considered relevant with r \> 0.6 and *P* \<  0.05.
